<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Human follicular B cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> possess a t(14;18) interchromosomal translocation that juxtaposes the putative proto-oncogene bcl-2 with the immunoglobulin (Ig) heavy chain locus </plain></SENT>
<SENT sid="1" pm="."><plain>We generated minigene constructs representing the bcl-2-Ig fusion gene found at this chromosomal breakpoint </plain></SENT>
<SENT sid="2" pm="."><plain>These constructs were placed into the germ line of mice to assess the effects of the t(14;18) during development </plain></SENT>
<SENT sid="3" pm="."><plain>The transgene demonstrates a lymphoid pattern of expression and uniformly results in an expanded follicular center cell population </plain></SENT>
<SENT sid="4" pm="."><plain>Hyperplastic splenic follicles coalesce to form massive regions of splenic white pulp </plain></SENT>
<SENT sid="5" pm="."><plain>Mice over 15 weeks of age demonstrate regional <z:hpo ids='HP_0002716'>lymphadenopathy</z:hpo> with abnormal cellular infiltrates </plain></SENT>
<SENT sid="6" pm="."><plain>The expanded lymphoid compartment is composed predominantly of polyclonal B220-positive, IgM/IgD-positive B cells </plain></SENT>
<SENT sid="7" pm="."><plain>Provocatively, the bcl-2-Ig transgene confers a survival advantage to a population of mature B cells assessed in vitro </plain></SENT>
<SENT sid="8" pm="."><plain>bcl-2-Ig transgenic mice document a prospective role for the t(14;18) in B cell growth and the pathogenesis of follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
</text></document>